Volume-5 ~ Issue-4
- Citation
- Abstract
- Reference
- Full PDF
Abstract: Free radical oxidative injury has been linked to myocardial infarction. This study has been taken to analyse the extent of oxidative injury and the antioxidant defensive mechanism by estimating Malonaldehyde and defensive markers such as serum Ceruloplasmin,serum Catalase antioxidant defence by S. Uric Acid and S. Ceruloplasmin. On 5th day of MI, oxidative and serum Uric acid at 6-12 hrs of onset of myocardial infarction and 5 days after thrombolytic therapy.Out of total 100 cases,50 age matched Control cases and 50 cases of known Myocardial infarction(with ECG report) are taken.Serum Malonaldehyde is estimated by thiobarbituric acid method.Serum Ceruloplasmin by O-diansidine method,serum Uric acid by uricase kit method.Serum Catalase activity by Spectrophotometric assay of complex of Molybdate and Hydrogen peroxide. Routine Blood sugar,blood urea,Serum creatinine,Haemoglobin %,HIV,HBs Ag also done .The data is statistically analysed and the mean,SD values are calculated. Student 't' test and 'p' values are also calculated.Statistically significant increase in Malonaldehyde, Uric acid,Ceruloplasmin in MI cases compared to controls with 'p' values <0.000 is seen.Significant decrease in serum Catalase in cases compared to patients with 'p' value <0.000 is seen.There is a significant decrease in serum Uric acid,Malonaldehyde,Ceruloplasmin and increase in serum Catalase after 5 days of Thrombolytic therapy.The area under table of the ROC curves of different parameter is compared.In present study there is significant increase in serum Malonaldehyde, Uric acid,Ceruloplasmin levels in MI cases compared to controls. Malonaldehyde is the best markers to indicate Oxidative Stress In MI.
Key Words: Ceruloplasmin , Malonaldehyde , MI-Myocardial infarction, Reactive oxygen species and Uric acid
[2] Dominguez C.,Ruiz E & Gussinye M.(1998).Oxidative stress at onset and early stages of type 1 diabetes in children and
adolescents.Diabetes care 21,1736-1742
[3] Mullarkey e.J., c.J.,Edelstein D and Brownlee M.(1990) free radical generation by early glycation products; a mechanism for
accelerated atherogenesis in diabetes. Biochem. Biophys.Res. Commun.173.932-939.
[4] American Heart Association(2000) http://www.american heart.org/statistics/index.html.
[5] CDC(1999) Deactive in deaths from heart disease and stroke-US., 1900-1999.M.M.W.S.R. 48,649-656.
[6] Herarre DJ(1977) reperfusion of the ischemic myocardium J.Mol. Cell Cardiol 9,605-606
[7] Gambhir J and Praphur KM(1995) Oxygen free radical and reperfusion injury Ind.Heart.J.47,112-113
[8] Ohlin H.M.Gustavsson C.g.Panter E.thorvinger,B and Ohlin A.K.(1995) transient release of Lipid peroxidation products as a non
invasive markers of successful reperfusion after thrombolysis and MI.Br. Ht. J 73,223-226.
[9] Beard T, Carrie D (1994). Production of oxygen free radicals in MI treated by thrombosis. Archives des maladies du 7,1289-1296
[10] Bickel C, Rupprecht HJ , Blankenbery S, Rippin g, Hafner g, Daunhauer a etal, Serum uric acid a
- Citation
- Abstract
- Reference
- Full PDF
Abstract:In this paper, we explore the use of statistical learning approaches to predict drug-target like proteins from their primary sequences in order to facilitate the rapid discovery of new potential therapeutic targets from the large quantity of sequences in human genome. It was found that the Support Vector Machine (SVM) algorithm with a fine-tuned Gaussian kernel was able to make reasonably accurate prediction, which showed its potential to be used in the genome scale rapid drug target discovery, as a novel in silico approach supplementary to the conventional experimental approaches.
Keyword: SVM, Therapeutic, PCA, ICA
pharmacophore?, Curr Med Chem, 7 (2000) 1101-12.
[2] Kurogi, Y. and Guner, O.F., Pharmacophore modeling and three-dimensional database searching for drug design using catalyst,
Curr Med Chem, 8 (2001) 1035-55.
[3] Klein, P., Kanehisa, M. and DeLisi, C., Prediction of protein function from sequence properties. Discriminant analysis of a data
base, Biochim Biophys Acta, 787 (1984) 221-6.
[4 ] Nakai, K., Kidera, A. and Kanehisa, M., Cluster analysis of amino acid indices for prediction of protein structure and function,
Protein Eng, 2 (1988) 93-100.
[5] Fetrow, J.S. and Skolnick, J., Method for prediction of protein function from sequence using the sequence-to-structure-to-function
paradigm with application to glutaredoxins/thioredoxins and T1 ribonucleases, J Mol Biol, 281 (1998) 949-68.
[6] Edwards, Y.J. and Cottage, A., Prediction of protein structure and function by using bioinformatics, Methods Mol Biol, 175 (2001)
341-75.
[7] Baxter, S.M. and Fetrow, J.S., Sequence- and structure-based protein function prediction from genomic information, Curr Opin
Drug Discov Devel, 4 (2001) 291-5.
[8] Hanselman, D.C. and Littlefield, B., Mastering MATLAB 6 : a comprehensive tutorial and reference, Prentice Hall, Upper Saddle
River, N.J., 2001, xviii, 814 p. pp.
[9] Hyvarinen, A., Fast and robust fixed-point algorithms for independent component analysis, Ieee Transactions on Neural Networks,
10 (1999) 626-634.
[10] Cai, C.Z., Han, L.Y., Ji, Z.L., Chen, X. and Chen, Y.Z., SVM-Prot: web-based support vector machine software for functional
classification of a protein from its primary sequence, Nucleic Acids Res, 31 (2003) 3692-7.
- Citation
- Abstract
- Reference
- Full PDF
| Paper Type | : | Research Paper |
| Title | : | Comparitive Study of Antihypertensive Treatment with Enalapril and Atenolol on Oxidative Stress and Insulin Resistance in Essential Hypertension |
| Country | : | India |
| Authors | : | Sankar P || Megha Ja || Zachariah Bobby |
| : | 10.9790/3008-0540811 ![]() |
Abstract: Hypertension is a heterogenous disorder in which patients can be stratified by pathophysiology characteristics that have a direct bearing, on the efficacy of specifically targeted antihypertensive medications, on the detection of potentially curable forms of hypertension and on the risk of cardiovascular complications.The study is done to compare the effect of antihypertensive treatment with Enalapril and Atenolol on oxidative stress and insulin resistance in patients with essential hypertension .Plasma Malonaldehyde(MDA), reduced Glutathione and Catalase were estimated to measure oxidative stress and fasting plasma Insulin to measure Insulin resistance....
Keywords – Atenolol,,Catalase,Enalapril,Insulin resistance,Malonaldehyde,oxidative stress
antioxidant power and free radicals in essential hypertension. Mol Cell Biochem. 2005 Sep; 277 (1-2):89-99.
[2] William F.Ganong. Review of Medical physiology.19th edition; 613: LANGE publication.
[3] Ward NC,Croft KD. Hypertension and oxidative stress. Clin Exp Pharmacol Physiol.2006; 33(9); 872-876.
[4] Digiesi V, Oliviero C, Giannò V, Rossetti M, Fiorillo C, Oradei A, Lenuzza M, Nassi P. Reactive metabolites of oxygen, lipid
peroxidation, total antioxidant capacity and vitamin E in essential arterial hypertension. Clin Ter. 1997 Nov; 148(11):515-9.
[5] Folli F,Khan CR et al.Angiotensin II inhibits the Insulin signalling in aortic smooth muscles at multiple levels:a potential role of Serine
Phosphorylation in Insulin/Angiotensin crosstalk .J .Clin Invest. 1997;100:2158-2169.
- Citation
- Abstract
- Reference
- Full PDF
| Paper Type | : | Research Paper |
| Title | : | In Vitro Drug Interactions Study of Lisinopril with Metformin |
| Country | : | Nigeria |
| Authors | : | Amorha, Kosisochi C., Akinleye, Moshood O. , Oyetunde, Olubukola O. |
| : | 10.9790/3008-0541218 ![]() |
Abstract: This study investigates the in vitro interactions of lisinopril with metformin which is important for the possible formulation of polypills comprising both drugs. The study was conducted using the USP apparatus II paddle method. The media used were buffer pH 1.2, 4.5, and 6.8 to simulate gastrointestinal tract pH. Lisinopril tablets (10 mg) were run in the presence of 500 mg metformin tablets and the degree of interaction was established after analyzing the dissolution samples with validated High Performance Liquid Chromatographic methods. The results indicated a statistically significant difference in the effect of lisinopril on the dissolution profile of metformin at pH 1.2, 4.5, and 6.8, with a decrease in the percentage of metformin released (p = 0.0052; p = 0.0037; and p = 0.0155, respectively). The effect of metformin on the dissolution profile of lisinopril was only statistically significant at pH 1.2 and 6.8 with an increase in the percentage of lisinopril released (p = 0.0062; p =0.0036, respectively), and no statistically significant difference at pH 4.5 (p = 0.7174). Thus, the co-administration of metformin with lisinopril could alter the bioavailability of both drugs. More studies may be conducted in vivo to further ascertain the level of interactions using animal or human model.
Keywords – Dissolution, Interactions, Lisinopril, Metformin, Polypills
290.
[2] A. Lee and H.I. Stockley, Drug interactions. In R. Walker and C. Whittlesea (Eds.), Clinical pharmacy and therapeutics 4
(Philadelphia: Churchill Livingstone Elsevier, 2007) 40 – 50.
[3] C. Triplitt, Drug interactions of medications commonly used in diabetes, Diabetes Spectrum, 19 (4), 2006, 202 – 211.
[4] J.A. Ansari, Drug interaction and pharmacists, Journal of Young Pharmacists, 2 (3), 2010, 326 – 331.
[5] P. Sleight, H. Pouleur and F. Zannad, Benefits, challenges, and registerability of the polypill, Eur Heart J., 27, 2006, 1651 – 1656.
[6] E. Lonn, J. Bosch, K.K. Teo, P. Pais, D. Xavier and S. Yusuf, The polypill in the prevention of cardiovascular diseases: key concepts, current status, challenges, and future directions, Circulation, 122, 2010, 2078 – 2088.
[7] S. Hughes, New polypill data predicts a halving of cardiovascular events, 2011, Available at
http://www.theheart.org/article/1231481.do, accessed on 30th June, 2012.
[8] E.Z. Soliman, S. Mendis, W.P. Dissanayake, N.P. Somasundaram, P.S. Gunaratne, I.K.Jayasinqne and C.D. Furberq, A polypill for
primary prevention of cardiovascular disease: a feasibility study of the World Health Organization, Trials, 12, 2011, 3.
[9] P. Muntner, D. Mann, R.P.Wildman, D. Shimbo, V. Fuster and M. Woodward, Projected impact of polypill use among US adults:
medication use, cardiovascular risk reduction, and side effects. Am Heart J, 161 (4), 2011, 719 – 725.
[10] N.J. Wald and M.R. Law, A strategy to reduce cardiovascular disease by more than 80%, BMJ, 326 (7404), 2003, 1419.
